CD40 in coronary artery disease: a matter of macrophages?

被引:0
|
作者
Matthijs F. Jansen
Maurits R. Hollander
Niels van Royen
Anton J. Horrevoets
Esther Lutgens
机构
[1] VU University Medical Centre,Department of Molecular Cell Biology and Immunology
[2] Academic Medical Centre,Department of Medical Biochemistry
[3] VU University Medical Center,Department of Cardiology
[4] Ludwig Maximilians University,Institute for Cardiovascular Prevention (IPEK)
来源
关键词
CD40; Macrophage; Atherosclerosis; Arteriogenesis; Neointima formation; Ischemic heart disease;
D O I
暂无
中图分类号
学科分类号
摘要
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), is the leading cause of mortality in the western world, with developing countries showing a similar trend. With the increased understanding of the role of the immune system and inflammation in coronary artery disease, it was shown that macrophages play a major role in this disease. Costimulatory molecules are important regulators of inflammation, and especially, the CD40L-CD40 axis is of importance in the pathogenesis of cardiovascular disease. Although it was shown that CD40 can mediate macrophage function, its exact role in macrophage biology has not gained much attention in cardiovascular disease. Therefore, the goal of this review is to give an overview on the role of macrophage-specific CD40 in cardiovascular disease, with a focus on coronary artery disease. We will discuss the function of CD40 on the macrophage and its (proposed) role in the reduction of atherosclerosis, the reduction of neointima formation, and the stimulation of arteriogenesis.
引用
收藏
相关论文
共 50 条
  • [21] CD40 LIGAND CD40 DEFICIENCY
    CASTIGLI, E
    FULEIHAN, R
    RAMESH, N
    TSITSIKOV, E
    TSYTSYKOVA, A
    GEHA, RS
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 37 - 39
  • [22] Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease
    Türker, S
    Güneri, S
    Akdeniz, B
    Özcan, MA
    Baris, N
    Badak, Ö
    Kirimli, Ö
    Yüksel, F
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (02): : 198 - 202
  • [23] Is there a correlation between soluble CD40 ligand levels, CRP and the extent of coronary artery disease in chronic stable angina?
    Gandhi, N.
    Gupta, S.
    Jenkins, N.
    Keevil, B.
    Brooks, N. H.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 227 - 227
  • [24] Polycystic ovary syndrome is associated with elevated serum soluble CD40 ligand, a marker of coronary artery disease.
    Oktem, M.
    Ozcimen, E. E.
    Uckuyu, A.
    Esinler, I.
    Bayraktar, N.
    Zeyneloglu, H. B.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S179 - S179
  • [25] C-REACTIVE PROTEIN BUT NOT SOLUBLE CD40 LIGAND IS ASSOCIATED WITH THE SEVERITY OF ANGIOGRAPHICALLY VERIFIED CORONARY ARTERY DISEASE
    Spasojevic-Kalimanovska, V.
    Veljic, S.
    Kotur-Stevuljevic, J.
    Bogavac-Stanojevic, N.
    Memon, L.
    Kalimanovska-Ostric, D.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 161 - 161
  • [26] CD40/CD40L system and vascular disease
    Santilli, F.
    Basili, S.
    Ferroni, P.
    Davi, G.
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2007, 2 (04) : 256 - 268
  • [27] Platelet activation and the CD40/CD40 ligand pathway: Mechanisms and implications for human disease
    Danese, S
    Fiocchi, C
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2005, 25 (02) : 103 - 121
  • [28] CD40/CD40L system and vascular disease
    F. Santilli
    S. Basili
    P. Ferroni
    G. Davì
    [J]. Internal and Emergency Medicine, 2007, 2 : 256 - 268
  • [29] Expression of CD40 and CD40 ligand in Bowen's disease and squamous cell carcinoma
    Amo, Y
    Ohta, Y
    Hamada, Y
    Tatsuta, M
    Katsuoka, K
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2000, 10 (06) : 439 - 442
  • [30] Soluble CD40 as a modulator of CD40 pathway
    Esposito, Pasquale
    Rampino, Teresa
    Dal Canton, Antonio
    [J]. IMMUNOLOGY LETTERS, 2012, 147 (1-2) : 85 - 86